CHK1 controls zygote pronuclear envelope breakdown by regulating F-actin through interacting with MICAL3

Area of Science:

• Cell Biology
• Developmental Biology
• Molecular Genetics

Background:

• Human zygote arrest at the pronuclei stage is a poorly understood cause of infertility.
• CHK1 (Checkpoint Kinase 1) mutations are implicated in this developmental failure.
• Understanding the molecular basis of zygote arrest is crucial for reproductive medicine.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying CHK1-mutation-induced zygote arrest.
• To identify key proteins and pathways affected by CHK1 dysfunction in early development.
• To investigate the role of CHK1 in pronuclear envelope breakdown and F-actin regulation.

Main Methods:

• Pre-pronuclei transfer experiments from mutant zygotes into normal cytoplasm.
• Analysis of F-actin organization and pronuclear envelope breakdown in affected zygotes.
• Co-immunoprecipitation and mass spectrometry on approximately 6000 mouse zygotes.
• Assessment of CHK1-MICAL3 interaction and MICAL3 enzymatic activity in gain-of-function mutants.

Main Results:

• Cytoplasmic transfer rescued CHK1-mutant zygote arrest, indicating cytoplasmic involvement.
• CHK1 mutants disrupt the F-actin meshwork, impairing pronuclear envelope breakdown.
• An interaction between CHK1 and MICAL3, an F-actin regulator, was identified.
• Gain-of-function CHK1 mutants enhance MICAL3 interaction and activity, leading to excessive F-actin depolymerization.

Conclusions:

• CHK1 dysfunction primarily affects cytoplasmic factors critical for zygote development.
• The CHK1-MICAL3 interaction and subsequent F-actin dysregulation are key to pronuclear envelope breakdown failure.
• These findings reveal a novel molecular pathway regulating the transition from meiosis to mitosis in mammalian zygotes.